Mirabella Financial Services LLP Repligen Corp Transaction History

Mirabella Financial Services LLP

  • $1.11 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022
SELL
$160.42 - $256.21 $373,939 - $597,225
-2,331 Reduced 36.62%
4,034 $755,000
Q2 2022

Aug 12, 2022
BUY
$140.68 - $188.02 $895,428 - $1.2 Million
6,365 New
6,365 $1.03 Million
Q1 2022

May 17, 2022
SELL
$161.19 - $257.96 $385,405 - $616,782
-2,391 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$247.59 - $304.47 $253,532 - $311,777
1,024 Added 74.91%
2,391 $633,000
Q3 2021

Nov 15, 2021
BUY
$194.77 - $324.21 $266,250 - $443,195
1,367 New
1,367 $395,000

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.2M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Mirabella Financial Services LLP Portfolio

Follow Mirabella Financial Services LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirabella Financial Services LLP, based on Form 13F filings with the SEC.

News

Stay updated on Mirabella Financial Services LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email